Health
Australian firm says its nasal spray reduced coronavirus growth in animal study – The Tribune
Ena Respiratory ready to test INNA-051 in human trials in less than four months
Sydney, September 28
Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly reduced the growth of the coronavirus in a recent study on animals.
A study on ferrets showed the product dubbed INNA-051, which could be used complementary to vaccines, lowered the levels of the virus that causes COVID-19 by up to 96%, the company said.
The study was led by British government agency Pu…
-
Business12 hours agoWarning! These ASX 200 shares were just downgraded
-
Business10 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General9 hours agoFatal house fire at Lake Illawarra under police investigation
-
Business11 hours agoAfter falling more than 20% on its FY25 result, are Inghams shares a buy the dip opportunity?